Abstract
Design of new inhibitors for novel targets is a very important problem especially in the current scenario with the world being plagued by COVID-19. Conventional approaches undertaken to this end, like, high-throughput virtual screening require extensive combing through existing datasets in the hope of finding possible matches. In this study we propose a computational strategy for de novo generation of molecules with high binding affinities to the specified target. A deep generative model is built using a stack augmented recurrent neural network for initially generating drug like molecules and then it is optimized using reinforcement learning to start generating molecules with desirable properties--primarily the binding affinity. The reinforcement learning section of the pipeline is further extended to multi-objective optimization showcasing the model's ability to generate molecules with a wide variety of properties desirable for drug like molecules, like, LogP, Quantitative Estimate of Drug Likeliness etc.. For multi-objective optimization, we have devised a novel strategy in which the property being used to calculate the reward is changed periodically. In comparison to the conventional approach of taking a weighted sum of all rewards, this strategy shows enhanced ability to generate a significantly higher number of molecules with desirable properties.
Supplementary materials
Title
Supplementary Information
Description
Figures and Tables of correlation plots of predicted binding affinities and ground truth, rewards functions, generated molecules, docking methodology details
Actions